Targeting DNA helicase CMG complex and NFκB2-driven drug-resistant transcriptional axis to effectively treat KRAS(G12D)-mutated pancreatic cancer
靶向DNA解旋酶CMG复合物和NFκB2驱动的耐药转录轴,以有效治疗KRAS(G12D)突变型胰腺癌
期刊:Experimental Hematology & Oncology
影响因子:13.5
doi:10.1186/s40164-025-00669-w
Xiao, Jeffrey; Kim, Joshua; Park, Brandon; Baylink, David J; Kwon, Cedric; Tran, Victoria; Lee, Scott; Codorniz, Kevin; Tan, Laren; Moreno, Pamela Lobo; Schill-Depew, Amy; Mirshahidi, Saied; De Semir, David; Hanna, Diana; Naqvi, Kiran; Cao, Huynh; Chen, Chien-Shing; Xiu, Joanne; Lenz, Heinz-Josef; Mirshahidi, Hamid; Reeves, Mark E; Xu, Yi